MEDISCA AUSTRALIA | Pediatric and Geriatric Compounding Laboratory Training | 31 Aug 2022
Both pediatric and geriatric patients present with similar concerns regarding medication intake, most notably, difficulty in swallowing a tablet or capsule, or the requirement for a lower dosage strength than is commercially available. Such a challenge places compounding in high demand as a means to achieve alternate dosage strengths and dosage forms in order to meet the unique needs of these patient populations. The most common dosage form prescribed to pediatric and geriatric patients are oral liquids because they circumvent the challenges of swallowing a tablet or capsule and allow for flexible dosing. Alternatively, child-friendly dosage forms, such as gummies, offers a unique avenue that the compounding pharmacist can take.
In this laboratory training, participants will be exposed to detailed procedures required to uphold exceptional compounding quality in the niche area of pediatric and geriatric therapy. With the implementation of innovative technologies and techniques, compounders will leave this course with the tools and knowledge needed to further their compounding practice.
- Riboflavin 100 mg Oral Gummy Gels
- Omeprazole 2 mg/mL Oral Liquid
- Amlodipine Besylate 1 mg/mL Oral Liquid
Note: Formulas are subject to change.
Pharmacists, pharmacy technicians, and other compounding personnel.
DURATION: 4 HOURS
1:00pm - 5:00pm
*Please arrive 15 minutes prior to start time to complete Check-In.
The training will take place at the MEDISCA Australia Facility.
SARA MONFARED, BPharm, BSc(PCOL), Grad Dip(PCOL), MPS
Technical Support Services Pharmacist, MEDISCA Australia
Note: Facilitators are subject to change.
Activity participants are required to achieve a 75% passing grade associated with a self-study learning assessment prior to attending the live event. Full attendance and the completion of an activity evaluation and practical skill set competency evaluation are a compulsory requirement to receive a certificate.